Effects of rapamycin, cyclosporin A, and dexamethasone on interleukin 5- induced eosinophil degranulation and prolonged survival

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 52, Issue 11, 1997, Pages 1095-1101

  Meng, Q ^a   Ying, S ^a   Corrigan, C J ^a   Wakelin, M ^a   Assoufi, B ^a   Moqbel, R ^a   Kay, A B ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Cyclosporin A; Degranulation; Dexamethasone; Eosinophil; Interleukin 5; Rapamycin; Survival

Indexed keywords

CYCLOSPORIN A; CYTOKINE; DEXAMETHASONE; RAPAMYCIN; RECOMBINANT INTERLEUKIN 5;

ARTICLE; ATOPY; CELL SURVIVAL; CELL VIABILITY; DEGRANULATION; EOSINOPHIL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0030667483     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1997.tb00181.x     Document Type: Article

References (31)

1. Wardlaw AJ, Moqbel R, Kay AB. Eosinophils: biology and role in disease. Adv Immunol 1995;60:151-266.
2. Clutterbuck EJ, Hirst EMA, Sanderson CJ. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow culture: comparison and interaction with IL-1, IL-3, IL-6, and GM-CSF. Blood 1989;73: 1504-12.
3. Stern M, Meagher L, Savill J, Haslett C. Apoptosis in human eosinophils. J Immunol 1992;148:3543-9.
4. Her E, Frazer J, Austen F, Owen WF Jr. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. J Clin Invest 1991;88:1982-7.
5. Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood 1992;79:3101-9.
6. Doi S, Gemou-Engesaeth V, Kay AB, Corrigan CJ. Polymerase chain reaction quantification of cytokine messenger RNA expression in peripheral blood mononuclear cells of patients with severe asthma: effect of glucocorticoid therapy. Clin Exp Allergy 1994;24:854-67.
7. Hamid Q, Azzawi M, Ying S, et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991;87:1541-6.
8. Robinson DS, Hamid Q, Ying S, et al. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5 and interferon-gamma cytokine gene expression. Am Rev Respir Dis 1993;148:401-6.
9. T) and modulation of interleukin-4, interleukin-5 and interferon- gamma cytokine gene expression within the bronchial mucosa. Am J Respir Crit Care Med 1996;153:551-6.
10. Alexander AG, Barnes NC, Kay AB. Trial of cyclosporin A in corticosteroid-dependent chronic severe asthma. Lancet 1992;339:324-8.
11. Dumont FJ, Staruch MJ, Koprak SL, Melino MR, Sigal NH. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. J Immunol 1990;144:251-5.
12. Metcalfe SM, Richards FM. Cyclosporine, FK506, and rapamycin. Some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells. Transplantation 1990;49:798-802.
13. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol Today 1992;13: 136-42.
14. Hultsch T, Rodriguez JL, Kaliner MA, Hohman RJ. Cyclosporin A inhibits degranulation of rat basophilic leukemia cells and human basophils. J Immunol 1990;144: 2659-64.
15. Dumont FJ, Su Q. Mechanism of action of the immunosuppressant rapamycin. Life Sci 1995;58:373-95.
16. Kita H, Ohinishi T, Okubo Y, Weilier D, Abrams JS, Gleich GJ, Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med 1991;174: 745-8.
17. Hansel TT, De Vries UM, Iff MT, et al. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991;145:105-12.
18. Winqvist I, Olofsson T, Olsson I. Mechanisms for eosinophil degranulation; release of the eosinophil cationic protein. Immunology 1984;51:1-8.
19. Miyasato M, Tsuda S, Nakama T, et al. Serum levels of eosinophil cationic protein reflect the state of in vitro degranulation of blood hypodense eosinophils in atopic dermatitis. J Dermatol 1996;23:382-8.
20. 4 production in asthma of different severities. Eur Respir J 1995;8:1465-72.
21. Kita H, Weiler DA, Abu-Ghazaleh R, Sanderson CJ, Gleich GJ. Release of granule protein from eosinophils cultured with IL-5. J Immunol 1992;149:629-35.
22. Hallsworth MP, Litchfield TM, Lee TH. Glucocorticoids inhibit granulocyte-macrophage colony-stimulating factor- 1 and interlukin-5 enhanced in vitro survival of human eosinophils. Immunology 1992;75:382-5.
23. Wallen N, Kita H, Weiler D, Gleich GJ. Glucocorticoids inhibit cytokine-mediated eosinophil survival. J Immunol 1991;147:3490-5.
24. Horn JT, Estridge T. FK506 and rapamycin modulate the functional activities of human peripheral blood eosinophils. Clin Immunol Immunopathol 1993;68:293-300.
25. Bierer BE, Hollander G, Fruman D, Burakoff SJ. Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology. Curr Opin Immunol 1993;5:763-73.
26. Mori A, Suko M, Nishizaki Y, et al. IL-5 production by CD4+ T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A. Int Immunol 1995;7:449-57.
27. Tagari P, Pechur E-I, Scheid M, Brown M, Ford- Hutchinson AW, Nicholson D. Activation of human eosinophils and differentiated HL-60 cells by interleukin 5. Int Arch Allergy Appl Immunol 1993;101:227-33.
28. Kita H, Abu-Ghazaleh R, Sanderson CJ, Gleich GJ. Effects of steroids on immunoglobulin-induced eosinophil degranulation. J Allergy Clin Immunol 1991;87: 70-7.
29. 4 in response to soluble agonists. J Immunol 1991;147:3855-61.
30. Haczku A, Alexander A, Brown P, et al. The effect of dexamethasone. cyclosporine, and rapamycin on T- lymphocyte proliferation in vitro: comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid- resistant chronic asthma. J Allergy Clin Immunol 1994; 93:510-19.
31. Ying S, Durham SR, Corrigan CJ, Hamid O, Kay AB. Phenotype of cells expressing mRNA for TH2 type (IL-4 and IL-5) and TH1 type (IL-2 and IFN-gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatics and normal control subjects. Am J Respir Cell Mol Biol 1995;12:477-87.